Diseases treated with TMSDepression

Depression is a disease that we still know little about. There may be many reasons for it. Symptoms of depression are, above all, permanent sadness and lack of joy (anhedonia).

Other symptoms include a lack of energy, fatigue, memory and concentration disorders, loss of interest, and isolation. As a result, it may lead to dissatisfaction with life and, in extreme cases, to the appearance of suicidal thoughts.

Approx. 60-70% of depressed patients respond to a greater or lesser degree to antidepressants. Unfortunately, the statistics are inevitable - 30% of patients are drug-resistant. Introducing another antidepressant gives only about a 5% chance of a therapeutic effect in this group. On the other hand, TMS therapy in the group of drug-resistant patients gives at least a 45% chance of recovery, which is about ten times more!

Depression is the main indication for the use of TMS therapy. The antidepressant effect of TMS has been scientifically proven and recognized by many scientific societies and institutions (such as FDA or NICE). In countries such as the USA, Great Britain, or the Netherlands, TMS in the treatment of drug-resistant depression is reimbursed, unfortunately not in Poland.

The primary stimulation area in depressive disorders is the dorsolateral prefrontal cortex (DLPFC). This area is a biological "integrated circuit" responsible, among other things, for managing emotions, cognitive functions, and social behavior. The dysfunction of this area is the essence of depression (link).
It is suspected that DLPFC deficiency may also arise due to exposure to severe or chronic stress or the action of toxic substances such as alcohol. The TMS effect normalizes the functioning of DLPFC, resulting in a clinical impact in the form of a reduction of clinical symptoms of depression.

Who do we treat?

  • people suffering from the so-called treatment-resistant depression (TRD)
  • depressed people in whom antidepressants give only modest improvement or have unbearable side effects;
  • depression in the course of bipolar disorder (bipolar disorder);
  • depression in pregnancy and postpartum depression during breastfeeding as an alternative to pharmacological treatment;

Let us help you

Check if you qualify for therapy

Efficacy of TMS in the treatment of depression

Results of treatment in Magwise clinics

Patients undergoing TMS therapy


Percentage of patients who felt an improvement